403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Avai Bio Inc
(MENAFN- Baystreet) 09:51 AM EST - Avai Bio Inc: Together with joint venture partner Austrianova, today announced that Prof. Walter H. Günzburg presented the companies' encapsulated-cell approach to sustained a-Klotho delivery at the Second Annual Klotho Conference, held September 18–19 in Miami. The 20-minute talk outlined how Austrianova's Cell-in-a-Box® technology is being applied through Klothonova, the 50/50 joint venture formed by Avaí Bio and Austrianova in 2025, to develop implanted, encapsulated cells designed for long-term production of a-Klotho. Avai Bio Inc
shares O are trading unchanged at $0.12.
Full Press Release:
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment